Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:RDDA Stock Latest News

Company AnnouncementsDr. Reddy’s Files SEC Form 6-K and Publishes Q2 FY27 Earnings Call Transcript2d ago6K RDY

Company AnnouncementsDr. Reddy’s Gets Favorable USFDA VAI Status at Srikakulam Plant3d ago6K RDY
Company AnnouncementsDr. Reddy’s Files Unmodified Auditor Review on September 2026 Interim Results6d ago6K RDY
Company AnnouncementsDr. Reddy’s Files Form 6-K, Publishes Q2 FY27 Earnings Call Recordings6d ago6K RDY
RatingsImproving Margins and EPS Upgrades Offset by Full Valuation, Supporting Hold Rating6d agoRDY

Dr. Reddy’s upgraded to Hold from Underperform at Jefferies

The FlyDr. Reddy’s upgraded to Hold from Underperform at Jefferies6d agoRDY

The FlyDr. Reddy’s upgraded to Neutral from Underweight at JPMorgan6d agoRDY

Company AnnouncementsDr. Reddy’s Earnings Call Highlights Growth Amid Headwinds1w agoRDY

Company AnnouncementsDr. Reddy’s Laboratories Files Q2 FY 2027 Unaudited Results with SEC and Indian Exchanges1w ago6K RDY
Company AnnouncementsDr. Reddy’s Elevates Aurigene CEO Akhil Ravi to Head API and Services1w ago6K RDY
Company AnnouncementsDr. Reddy’s Releases Q2 FY27 Unaudited Results Presentation1w ago6K RDY
Company AnnouncementsDr. Reddy’s Interim Q2 FY 2026 Results Receive Clean Auditor Review1w ago6K RDY

RDY Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-EarningsRDY Earnings Report this Week: Is It a Buy, Ahead of Earnings?1w agoRDY

Company AnnouncementsDr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant2w ago6K RDY

The FlyDr. Reddy’s upgraded to Outperform from Neutral at BNP Paribas2w agoRDY

Company AnnouncementsDr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-113w ago6K RDY
Company AnnouncementsDr. Reddy’s Sets October 23 Date for Q2 FY27 Results and Global Earnings Call3w ago6K RDY
Company AnnouncementsDr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material3w ago6K RDY
The FlyDr. Reddy’s double-upgraded to Buy from Sell at Citi1M agoRDY

Dr. Reddy’s Schedules October 23 Board Meet, Closes Trading Window Ahead of Q2 Results

Company AnnouncementsDr. Reddy’s Schedules October 23 Board Meet, Closes Trading Window Ahead of Q2 Results1M ago6K RDY

Company AnnouncementsDr. Reddy’s Schedules Nomura-Led Investor Meet in Hyderabad1M ago6K RDY

Company AnnouncementsDr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market1M ago6K RDY